21 h. ago Apple stock rallies following strong iPhone 17 sales in U.S. and China

Apple stock rallies following strong iPhone 17 sales in U.S. and China  CNBC

Politics

21 h. ago Apple closes at record after strong iPhone 17 sales report for U.S., China

Apple closes at record after strong iPhone 17 sales report for U.S., China  CNBC

Politics

31 h. ago iPhone 17 outsells predecessor by 14% in early China, US sales, research firm says

iPhone 17 outsells predecessor by 14% in early China, US sales, research firm says  Reuters

Economics

5 d. ago S&P 500 gains as strong earnings overshadow China trade fight, Bank of America rallies: Live updates 108212091

S&P 500 gains as strong earnings overshadow China trade fight, Bank of America rallies: Live updates 108212091  CNBC

Economics

5 d. ago Apple Stock Edges Up Premarket: CEO Tim Cook Pledges Investment In China During Beijing Visit

Apple Stock Edges Up Premarket: CEO Tim Cook Pledges Investment In China During Beijing Visit  Stocktwits

Economics

7 d. ago iPhone Air will go on sale in China later this week, per report

iPhone Air will go on sale in China later this week, per report  9to5Mac

Politics

7 d. ago Apple announces iPhone Air will go on sale in China later this week

Apple announces iPhone Air will go on sale in China later this week  9to5Mac

Politics

1 week ago Applied Materials’ SWOT analysis: semiconductor stock faces china headwinds

Applied Materials’ SWOT analysis: semiconductor stock faces china headwinds  Investing.com

Politics

2 w. ago Applied Materials stock rating reiterated by Cantor Fitzgerald despite China concerns

Applied Materials stock rating reiterated by Cantor Fitzgerald despite China concerns  Investing.com

Politics

2 w. ago Applied Materials Stock Falls Along With Lam Research and KLA. China Revenue Is at Risk.

Applied Materials Stock Falls Along With Lam Research and KLA. China Revenue Is at Risk.  Barron's

Events

2 w. ago Chinese healthcare, biotech firms flock to Hong Kong for IPOs

Eleven Chinese healthcare and biotechnology companies filed applications to list on the Hong Kong stock exchange in the last two days of September, taking advantage of an ongoing investment boom in the sector. The best-known names among them are online healthcare services firm We Doctor Holdings, Sichuan Biokin Pharmaceutical – known for a US$8.4 billion licensing deal with US-based Bristol Myers Squibb (BMS) – and profitable cancer-drug developer Betta Pharmaceuticals. Other initial public...

Economics